Critical amino acids in the lymphocyte function-associated antigen-1 I domain mediate intercellular adhesion molecule...

Area of Science:

• Immunology
• Molecular Biology
• Cell Adhesion

Background:

• Leukocyte function-associated antigen 1 (LFA-1) is a key integrin mediating leukocyte adhesion.
• Intercellular Adhesion Molecule 3 (ICAM-3) is a ligand for LFA-1, crucial for initiating immune responses.
• Understanding LFA-1 ligand binding specificity is vital for immune regulation.

Purpose of the Study:

• To identify specific amino acid residues in the LFA-1 alpha-chain (CD11a) I domain responsible for ICAM-3 binding.
• To investigate the functional subdomains within the CD11a I domain for differential ligand recognition.
• To explore the potential of targeting ICAM-3 interactions for therapeutic intervention.

Main Methods:

• Construction and analysis of human/murine I domain chimeras of CD11a.
• Site-directed mutagenesis to identify critical amino acid residues.
• Assessment of ICAM-3 and ICAM-1 binding to modified LFA-1.
• Evaluation of synthetic peptides containing identified motifs for functional inhibition.

Main Results:

• The Ile-Lys-Gly-Asn motif in the CD11a I domain is essential for ICAM-3 binding, but not ICAM-1 binding.
• Distinct functional subdomains within the CD11a I domain dictate specific ligand binding.
• Aspartic acid at position 137 is critical for both ICAM-3 and ICAM-1 binding to LFA-1.
• A peptide containing the Ile-Lys-Gly-Asn motif inhibited ICAM-3-dependent T cell adhesion and proliferation.

Conclusions:

• The CD11a I domain possesses distinct regions for specific ligand interactions, differentiating ICAM-3 from ICAM-1 binding.
• ICAM-3 plays a significant role in leukocyte adhesion and T cell activation.
• Targeting the ICAM-3 binding site on LFA-1 with specific peptides may offer a novel strategy for immunosuppression.